Engineering blood vessels by gene and cell therapy

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Surgery

Background:

• Cardiovascular diseases are a leading global cause of death, often necessitating bypass surgery.
• Atherosclerosis leads to arterial narrowing, reducing blood flow and requiring interventions like bypass grafting.
• Current bypass surgeries predominantly use autologous grafts, but synthetic grafts are employed when autologous options are unavailable, despite higher failure rates due to thrombosis and scarring.

Purpose of the Study:

• To review the advancements in tissue engineering for vascular grafts.
• To explore the integration of cell and gene therapies in creating improved vascular grafts.
• To highlight the potential of these novel approaches in overcoming limitations of current synthetic grafts.

Main Methods:

• Review of current literature on vascular graft technologies.
• Analysis of cell and gene therapy applications in tissue engineering.
• Evaluation of biocompatibility and durability of engineered vascular grafts.

Main Results:

• Tissue engineering combined with cell and gene therapy shows significant promise for developing biocompatible and durable vascular grafts.
• These advanced therapies aim to reduce failure rates associated with synthetic grafts, such as thrombosis and scar formation.
• The review consolidates current knowledge and future directions in this rapidly evolving field.

Conclusions:

• Engineered vascular grafts utilizing cell and gene therapies represent a significant advancement in regenerative medicine for cardiovascular applications.
• This approach holds the potential to improve patient outcomes by providing more durable and biocompatible alternatives to synthetic grafts.
• Further research and clinical translation are crucial to fully realize the benefits of tissue-engineered vascular grafts.